MPTRVT

Cystic Fibrosis (CF) is an autosomal recessive disorder affecting the lungs, pancreas, intestine and liver. CF is the most common in Caucasians with an incidence rate 1:2500 newborns. CF is caused by mutation in the gene for the protein cystic fibrosis transmembrane conductance regulator (CTFR) [1,2]. Large-scale neonatal screening for CF is performed by indentification of increased levels of immunoreactive trypsinogen (IRT) in blood.

Reliable Newborn Screening devices provided by Labsystems Diagnostics.

Biocard™ Hepatitis B Surface antigen in vitro diagnostic kit in dipstick method is based on the antigen capture assay for the detection of HBsAg in human serum/plasma by lateral flow immunochromatography method.All the accessories needed for the sampling and testing are included.Works on Serum/Plasma.Results can be obtained in 20 minutes

Microtomy at the touch of a button The first of its kind this fully automated and programmable microtome aligns and trims blocks with optimal precision section after section.

• Specific antigens
• Internal and external quality monitoring
• Long shelf life even for opened kit components (6 months)
• Higher throughput and objective reading compared to MIF
• Interchangeable reagents and similar procedures

Labsystems Diagnostics’ Mycoplasma pneumoniae IgG, IgA and IgM EIA tests are solid-phase enzyme immunoassays for the detection of IgG, IgA and IgM antibodies, respectively, to Mycoplasma pneumoniae in human serum or plasma.Mycoplasma pneumoniae IgG EIA, 96 wells, Cat. 6111400Mycoplasma pneumoniae IgA EIA, 96 wells, Cat. 6111410Mycoplasma